BIOMAT Database Logo BIOMAT Database Logo

Isolation and characterization of a novel human bladder cancer cell line: BK10. 1998

K M Roberson, and D R Yancey, and H Padilla-Nash, and D W Edwards, and W Nash, and S Jacobs, and G M Padilla, and W A Larchian, and C N Robertson
Department of Surgery, Duke University Medical Center, Durham, North Carolina 27710, USA.

Molecular studies of bladder carcinomas have aided in determining causative genetic events and the prognosis of cancers endowed with certain abnormalities. In vitro bladder cancer characterization of key cytogenetic alterations is useful for study of molecular changes that may promote oncogenic events. In our laboratory, a novel human bladder cancer cell line, BK10, has been established in vitro and passaged for more than 20 mo. This new bladder cancer cell line (BK10) was derived from bladder tissue containing grade III-IV/IV transitional cell carcinoma. Bladder cancer tissue was obtained at the time of radical cystoprostatectomy extirpation. Cell cultures derived from this surgical sample exhibited an epithelial morphology and expressed epithelial cytokeratins. Immunostains of BK10 were negative for prostate specific antigen (PSA), fibronectin, smooth muscle actin alpha, and desmin. Karyotypic analysis revealed an aneuploid chromosomal content <4n> with many numerical and structural abnormalities previously linked to bladder oncogenesis. Translocations occurred in chromosomes 1, 2, 3, 4, 5, 6, 7, 8, 9, 11, 13, 14, 15, 16, 17, 19, 20, 21, 22, X and Y. G-banding analysis revealed rearrangements involving chromosomes 9q and 17p, and the location of the ab11 oncogene and the p53 gene, respectively. The availability of this bladder cancer cell line will provide a useful tool for the further study of bladder carcinoma oncogenesis and gene therapy.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D007621 Karyotyping Mapping of the KARYOTYPE of a cell. Karyotype Analysis Methods,Analysis Method, Karyotype,Analysis Methods, Karyotype,Karyotype Analysis Method,Karyotypings,Method, Karyotype Analysis,Methods, Karyotype Analysis
D008297 Male Males
D008819 Mice, Nude Mutant mice homozygous for the recessive gene "nude" which fail to develop a thymus. They are useful in tumor studies and studies on immune responses. Athymic Mice,Mice, Athymic,Nude Mice,Mouse, Athymic,Mouse, Nude,Athymic Mouse,Nude Mouse
D001749 Urinary Bladder Neoplasms Tumors or cancer of the URINARY BLADDER. Bladder Cancer,Bladder Neoplasms,Cancer of Bladder,Bladder Tumors,Cancer of the Bladder,Malignant Tumor of Urinary Bladder,Neoplasms, Bladder,Urinary Bladder Cancer,Bladder Cancers,Bladder Neoplasm,Bladder Tumor,Cancer, Bladder,Cancer, Urinary Bladder,Neoplasm, Bladder,Neoplasm, Urinary Bladder,Tumor, Bladder,Tumors, Bladder,Urinary Bladder Neoplasm
D002295 Carcinoma, Transitional Cell A malignant neoplasm derived from TRANSITIONAL EPITHELIAL CELLS, occurring chiefly in the URINARY BLADDER; URETERS; or RENAL PELVIS. Carcinomas, Transitional Cell,Cell Carcinoma, Transitional,Cell Carcinomas, Transitional,Transitional Cell Carcinoma,Transitional Cell Carcinomas
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

K M Roberson, and D R Yancey, and H Padilla-Nash, and D W Edwards, and W Nash, and S Jacobs, and G M Padilla, and W A Larchian, and C N Robertson
Isolation and characterization of a novel bladder cancer cell line: inhibition by epidermal growth factor.
October 1998, In vitro cellular & developmental biology. Animal,
K M Roberson, and D R Yancey, and H Padilla-Nash, and D W Edwards, and W Nash, and S Jacobs, and G M Padilla, and W A Larchian, and C N Robertson
Characterization of a BMS-181174-resistant human bladder cancer cell line.
January 1997, British journal of cancer,
K M Roberson, and D R Yancey, and H Padilla-Nash, and D W Edwards, and W Nash, and S Jacobs, and G M Padilla, and W A Larchian, and C N Robertson
Characterization of a new human bladder cancer cell line, UCRU-BL-28.
September 1993, The Journal of urology,
K M Roberson, and D R Yancey, and H Padilla-Nash, and D W Edwards, and W Nash, and S Jacobs, and G M Padilla, and W A Larchian, and C N Robertson
Biochemical characterization of a mitomycin C-resistant human bladder cancer cell line.
March 1996, International journal of cancer,
K M Roberson, and D R Yancey, and H Padilla-Nash, and D W Edwards, and W Nash, and S Jacobs, and G M Padilla, and W A Larchian, and C N Robertson
Establishment and characterization of a new cell line from human bladder cancer (JMSU1).
January 1995, Urological research,
K M Roberson, and D R Yancey, and H Padilla-Nash, and D W Edwards, and W Nash, and S Jacobs, and G M Padilla, and W A Larchian, and C N Robertson
The isolation and partial characterization of a radiation-sensitive clone of a human bladder carcinoma cell line.
December 1991, Radiation research,
K M Roberson, and D R Yancey, and H Padilla-Nash, and D W Edwards, and W Nash, and S Jacobs, and G M Padilla, and W A Larchian, and C N Robertson
Characterization of a novel, trastuzumab resistant human breast cancer cell line.
January 2010, Frontiers in bioscience (Elite edition),
K M Roberson, and D R Yancey, and H Padilla-Nash, and D W Edwards, and W Nash, and S Jacobs, and G M Padilla, and W A Larchian, and C N Robertson
Isolation and characterization of a near-haploid human cell line.
November 1999, Experimental cell research,
K M Roberson, and D R Yancey, and H Padilla-Nash, and D W Edwards, and W Nash, and S Jacobs, and G M Padilla, and W A Larchian, and C N Robertson
Establishment and characterization of a doxorubicin-resistant human bladder cancer cell line (MGH-U1R).
August 1988, The Journal of urology,
K M Roberson, and D R Yancey, and H Padilla-Nash, and D W Edwards, and W Nash, and S Jacobs, and G M Padilla, and W A Larchian, and C N Robertson
[Establishment and characterization of a cis-diamminedichloro platinum-resistant human bladder cancer cell line].
July 1991, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology,
Copied contents to your clipboard!